Views & Analysis Rethinking rare diseases: treat the whole patient CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.
Debates & Insight Sponsored Patient centricity: Identifying how Boehringer Ingelheim UK ... Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.
Views & Analysis Clinical trial lay summaries: a clearer picture emerges EC wants pharma to make clinical trial results more patient-friendly.
Views & Analysis Disruptive forces reshaping healthcare business models Several elements are coming together to transform companies’ approaches to meeting health needs.
Articles Stop being control freaks: pharma’s challenge in involving p... Lode Dewulf, chief patient affairs officer at UCB, tells Paul Tunnah how patient-centricity is evolving, and describes how pharma still needs to adapt.
News Telix to buy radiopharma rival ITM for $1.65bn upfront Telix Pharma has reached a deal to acquire ITM, extending a wave of consolidation in the radiopharma category over the last couple of years.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
